X4 Pharmaceuticals (XFOR) Other Operating Expenses (2017 - 2024)
X4 Pharmaceuticals (XFOR) reported Other Operating Expenses of $105.0 million for Q2 2024, up 91.87% quarter-over-quarter from $54.7 million in Q1 2024.
X4 Pharmaceuticals (XFOR) Other Operating Expenses (2017 - 2024) Analysis & Trends
X4 Pharmaceuticals has reported Other Operating Expenses for 5 years, with the latest figure at $105.0 million in Q2 2024.
- For the quarter ending Q2 2024, Other Operating Expenses changed N/A year-over-year to $105.0 million; the trailing twelve-month figure through Mar 2025 stood at $105.0 million (up 91.87% YoY), and the FY2024 full-year result was $105.0 million, changed N/A from the prior year.
- Other Operating Expenses for Q2 2024 stood at $105.0 million, up from $54.7 million in the prior quarter.
- The five-year high for Other Operating Expenses was $105.0 million in Q2 2024, with the low at -$509000.0 in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | X4 Pharmaceuticals | 156.06 Mn | 156.06 Mn | 2.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 105.00 Mn |
| Mar 31, 2024 | 54.72 Mn |
| Dec 31, 2022 | -509,000.00 |
| Mar 31, 2022 | 509,000.00 |
| Dec 31, 2019 | 104,000.00 |
| Sep 30, 2019 | -4.00 Mn |
| Jun 30, 2019 | -12.90 Mn |
| Mar 31, 2019 | -16.26 Mn |
| Jun 30, 2018 | -18.62 Mn |
| Mar 31, 2018 | -20.24 Mn |
| Dec 31, 2017 | 13.89 Mn |